RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in…
Study in Molecular Cancer Therapeutics is first to show that inhibiting FAK with CFAK-Y15 is an effective approach to controlling growth of glioblastoma tumors.
(PRWeb December 28, 2012)
Read the full story at http://www.prweb.com/releases/2012/12/prweb10265721.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.